PharmaSGP Holding Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from PharmaSGP Holding SE
Access all reports
PharmaSGP Holding SE is a health technology company that specializes in the development, sale, and marketing of non-prescription (over-the-counter) drugs, chemical-free painkillers, and herbal medicines. Established in 2012 and headquartered in Gräefelfing, Germany, the company offers a broad range of healthcare products targeting various medical conditions without the use of chemical substances. Its portfolio includes well-known brands such as Baldriparan, Formigran, Spalt, Kamol, RubaXX, Restaxil, DESEO, and NERADIN, each designed to address specific health concerns like sleep disorders, pain relief, rheumatic pain, and sexual health, among others. Its shares are listed on the XETRA.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
PSG
Country
🇩🇪 Germany